LifeTech Scientific's Total Assets for the quarter that ended in Dec. 2025 was $711.7 Mil.
Warning Sign:
If a company builds assets at 17.2% a year, faster than its revenue growth rate of 13% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, LifeTech Scientific's average Total Assets Growth Rate was 7.50% per year.
During the past 3 years, the average Total Assets Growth Rate was 10.20% per year.
During the past 5 years, the average Total Assets Growth Rate was 17.20% per year.
During the past 10 years, the average Total Assets Growth Rate was 22.20% per year.
During the past 13 years, LifeTech Scientific's highest 3-Year average Total Assets Growth Rate was 62.50%. The lowest was 10.20%. And the median was 26.90%.
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
LifeTech Scientific's Asset Turnover for the quarter that ended in Dec. 2025 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
LifeTech Scientific Total Assets Related Terms
LifeTech Scientific Total Assets Historical Data
* Premium members only.
The historical data trend for LifeTech Scientific's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
LifeTech Scientific's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeTech Scientific (LFTSF) has a Total Assets of $711.7 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on LifeTech Scientific and its competitors.
Is LifeTech Scientific's Total Assets too high?
LifeTech Scientific's current Total Assets is $711.7 Mil. Overall, LifeTech Scientific has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's Total Assets compare to ABT and SYK?
LifeTech Scientific's Total Assets of $711.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on LifeTech Scientific and its competitors. LifeTech Scientific's current Total Assets is $711.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (LFTSF) has a current Total Assets of $711.7 Mil. The stock's GF Value™ is $0.36, compared to a current price of $0.23 — trading 35.1% below its estimated fair value. The current Total Assets is $711.7 Mil. LifeTech Scientific's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For LifeTech Scientific (LFTSF), the current Total Assets is $711.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeTech Scientific (LFTSF) Overvalued in 2026?
Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued.
The current stock price of $0.23 is trading 35.1% below its estimated GF Value™ of $0.36.
Key valuation signals for LFTSF:
Total Assets: $711.7 Mil
GF Value™: $0.36 vs. price of $0.23 (35.1% below fair value)
No single metric tells the full story. See the LFTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score
Get the complete analysis for LFTSF
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFTSF has been successfully added to your 
